Skip to main content

Treatment of chronic hyponatremia: now we know how, but do we know when or if?

Publication ,  Journal Article
Greenberg, A; Lehrich, RW
Published in: J Am Soc Nephrol
April 2010

Duke Scholars

Published In

J Am Soc Nephrol

DOI

EISSN

1533-3450

Publication Date

April 2010

Volume

21

Issue

4

Start / End Page

552 / 555

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Tolvaptan
  • Hyponatremia
  • Humans
  • Chronic Disease
  • Benzazepines
  • Antidiuretic Hormone Receptor Antagonists
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Greenberg, A., & Lehrich, R. W. (2010). Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol, 21(4), 552–555. https://doi.org/10.1681/ASN.2010020157
Greenberg, Arthur, and Ruediger W. Lehrich. “Treatment of chronic hyponatremia: now we know how, but do we know when or if?J Am Soc Nephrol 21, no. 4 (April 2010): 552–55. https://doi.org/10.1681/ASN.2010020157.
Greenberg A, Lehrich RW. Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol. 2010 Apr;21(4):552–5.
Greenberg, Arthur, and Ruediger W. Lehrich. “Treatment of chronic hyponatremia: now we know how, but do we know when or if?J Am Soc Nephrol, vol. 21, no. 4, Apr. 2010, pp. 552–55. Pubmed, doi:10.1681/ASN.2010020157.
Greenberg A, Lehrich RW. Treatment of chronic hyponatremia: now we know how, but do we know when or if? J Am Soc Nephrol. 2010 Apr;21(4):552–555.

Published In

J Am Soc Nephrol

DOI

EISSN

1533-3450

Publication Date

April 2010

Volume

21

Issue

4

Start / End Page

552 / 555

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Tolvaptan
  • Hyponatremia
  • Humans
  • Chronic Disease
  • Benzazepines
  • Antidiuretic Hormone Receptor Antagonists
  • 3202 Clinical sciences
  • 1103 Clinical Sciences